CYAN Share Price | Cyanotech Corp. Stock Analysis & Recommendation

Q: What does Cyanotech Corp. do?

Overview:Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market and operates within the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.Financial Snapshot:- Most recent Net Sales: 6 Million (Quarterly Results - Dec 2024)- Most recent Net Profit: 0 Million (Quarterly Results - Dec 2024)- Market-cap: USD 2.57 Million (Micro Cap)Key Metrics:- P/E: NA (Loss Making)- Industry P/E: NA- Dividend Yield: 0.00%- Debt Equity: 0.82- Return on Equity: -49.02%- Price to Book: 0.27Contact Details:- Address: 73-4460 Queen Kaahumanu Hwy Ste 102, KAILUA KONA HI: 96740-2637- Tel: ['1 808 3261353', '1 310 3466131']- Fax: 1 808 3294533- Website: https://www.cyanotech.com/

Q: Is Cyanotech Corp. overvalued or undervalued?

As of 9 November 2022, the valuation grade for Cyanotech Corp. has moved from expensive to risky, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued given its current financial metrics, particularly with a Price to Book Value of 0.30, an EV to EBITDA of -5.14, and a ROE of -49.02%. In comparison to its peers, Cyanotech Corp. has a less favorable EV to EBITDA ratio than Upexi, Inc. at -37.9754 and Natural Alternatives International, Inc. at -7.6875, both of which also carry a risky valuation. The company's stock has significantly underperformed against the S&P 500, with a one-year return of -57.57% compared to the index's 17.14%, reinforcing the notion that it is overvalued in the current market context.

Q: Is Cyanotech Corp. technically bullish or bearish?

As of 9 September 2025, the technical trend for Cyanotech Corp. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength. Key indicators driving this stance include a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and bearish signals from both the Dow Theory and Bollinger Bands on the monthly timeframe. Additionally, the stock has significantly underperformed the S&P 500 across multiple periods, with a 1-year return of -57.57% compared to the S&P 500's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.2 k

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

98.88%

Held by 1 DIIs

Promoter

0.00%

How big is Cyanotech Corp.?

22-Jun-2025

As of Jun 18, Cyanotech Corp. has a market capitalization of 2.57 million and reported net sales of 23.88 million with a net profit of -4.65 million over the latest four quarters. Shareholder's funds are at 11.81 million, and total assets are 25.11 million.

View full answer

What does Cyanotech Corp. do?

22-Jun-2025

Cyanotech Corporation produces natural products from microalgae for the nutritional supplements market and operates as a micro-cap company with a market cap of $2.57 million. As of December 2024, it reported net sales of $6 million but no net profit.

View full answer

Who are in the management team of Cyanotech Corp.?

22-Jun-2025

As of March 2022, the management team of Cyanotech Corp. includes Mr. Michael Davis as the Independent Chairman and Dr. Gerald Cysewski as the CEO and Executive Vice Chairman, along with Independent Directors Ms. Nancy Katz, Mr. Walter Menzel, Mr. David Mulder, and Mr. David Vied.

View full answer

Is Cyanotech Corp. overvalued or undervalued?

20-Sep-2025

As of November 9, 2022, Cyanotech Corp. is considered overvalued and has a risky valuation outlook due to poor financial metrics and significant underperformance compared to the S&P 500.

View full answer

Is Cyanotech Corp. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Cyanotech Corp. is in a bearish trend with weak strength, indicated by bearish MACD and moving averages, along with significant underperformance against the S&P 500, showing a 1-year return of -57.57%.

View full answer

Compare Cyanotech Corp. with Similar Stocks

iBio, Inc.Flora Growth Corp.Guardion Health Sciences, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.47
The company has been able to generate a Return on Equity (avg) of 2.21% signifying low profitability per unit of shareholders funds

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 3 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.03

Return on Equity

-22.02%

Price to Book

0.37

Revenue and Profits:

Net Sales:

6 Million

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

67.55%

6 Months

36.49%

1 Year

40.28%

2 Years

-34.42%

3 Years

-62.59%

4 Years

-82.16%

5 Years

-86.35%

Cyanotech Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-4.99%

EBIT Growth (5y)

-211.82%

EBIT to Interest (avg)

-1.47

Debt to EBITDA (avg)

1.13

Net Debt to Equity (avg)

0.89

Sales to Capital Employed (avg)

1.27

Tax Ratio

0.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.13%

ROCE (avg)

2.41%

ROE (avg)

2.21%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.30

EV to EBIT

-2.68

EV to EBITDA

-5.14

EV to Capital Employed

0.62

EV to Sales

0.45

PEG Ratio

Dividend Yield

ROCE (Latest)

-22.97%

ROE (Latest)

-49.02%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.12%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -7.94% vs 1.61% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -50.00% vs -200.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.80",
          "val2": "6.30",
          "chgp": "-7.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-0.60",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-129.40%",
          "val2": "-70.20%",
          "chgp": "-5.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 4.76% vs -0.43% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 39.62% vs -55.88% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.20",
          "val2": "23.10",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-2.50",
          "chgp": "76.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.20",
          "val2": "-5.30",
          "chgp": "39.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-103.60%",
          "val2": "-199.00%",
          "chgp": "9.54%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

5.80

6.30

-7.94%

Operating Profit (PBDIT) excl Other Income

-0.30

0.00

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-0.90

-0.60

-50.00%

Operating Profit Margin (Excl OI)

-129.40%

-70.20%

-5.92%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is -7.94% vs 1.61% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -50.00% vs -200.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

24.20

23.10

4.76%

Operating Profit (PBDIT) excl Other Income

-0.60

-2.50

76.00%

Interest

0.70

Exceptional Items

0.00

Consolidate Net Profit

-3.20

-5.30

39.62%

Operating Profit Margin (Excl OI)

-103.60%

-199.00%

9.54%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 4.76% vs -0.43% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 39.62% vs -55.88% in Mar 2024

All Annual Results

Company CV

About Cyanotech Corp.

Cyanotech Corp.

Pharmaceuticals & Biotechnology

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company's products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, to enhance skin, and to support eye and joint health. The Company cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived. The Company produces its algae in Hawaii and manufactures the finished products in Hawaii and California.

Company Coordinates

Company Details

73-4460 Queen Kaahumanu Hwy Ste 102 , KAILUA KONA HI : 96740-2637

Tel: 1 808 32613531 310 3466131

https://www.cyanotech.com/

Registrar Details

Cyanotech Corp.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cyanotech Corp.?

Watch in Real-Time

What does Cyanotech Corp. do?

Who are in the management team of Cyanotech Corp.?

Is Cyanotech Corp. overvalued or undervalued?

Is Cyanotech Corp. technically bullish or bearish?

Compare Cyanotech Corp. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Risky - Negative EBITDA

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Mar'25

About Cyanotech Corp.

Company Coordinates